Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of the Bifidobacterium Longum BL21 on BMI, Metabolic Indicators, and Gut Microbiota in Overweight/Obese Adults
Sponsor: Qilu Hospital of Shandong University
Summary
The goal of this study is to investigate the effects of Bifidobacterium longum subspecies BL21 on BMI, metabolic indicators, and changes in gut microenvironment microbiota in overweight/obese adults. The blood, urine, and feces samples of the subjects need to be collected at 0,4 and 8 week and promptly tested in the laboratory. During the intervention period, all groups of subjects were required to take the corresponding products daily and record adverse reactions.
Official title: Effects of Supplementing the Bifidobacterium Longum BL21 on BMI, Metabolic Indicators, and Gut Microbiota in Overweight/Obese Adults: a Randomized, Double-blind, Placebo-controlled Trial
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
72
Start Date
2023-11-29
Completion Date
2024-07-30
Last Updated
2026-07-22
Healthy Volunteers
No
Conditions
Interventions
Probiotics
Bifidobacterium Longum BL21 or placebo for 8 weeks.
Locations (1)
Qilu hospital
Jinnan, Shandong, China